TL;DR — BIOMEDevice Silicon Valley 2026 still exists — it's just been renamed. Informa Markets rebranded the show to MEDevice Silicon Valley to align with the MD&M event family. The 2026 edition runs November 18–19, 2026 at the Santa Clara Convention Center. Same venue, same Informa Markets team, same Bay Area medtech audience: ~1,200 attendees, 150+ exhibitors, 20+ hours of education across AI medtech, IoT, connected health, additive manufacturing, diagnostics, and regulatory strategy. Booth space starts at ~$50/sqft. Free expo admission with pre-registration ($199 at the door). For the full exhibitor-side breakdown, see the MEDevice Silicon Valley 2026 conference profile.

BIOMEDevice Silicon Valley 2026: The Rebrand You Need to Know About

If you typed "BIOMEDevice Silicon Valley 2026" into a search bar expecting to find the same show you've exhibited at or attended in previous years, here's the headline: the show still exists, the dates and venue have not changed, but the name has. Informa Markets, the organizer behind the entire MD&M trade-show family, retired the "BIOMEDevice" brand at the end of 2025 and folded the Silicon Valley regional event into the same naming convention used by every other event in the portfolio. The show is now MEDevice Silicon Valley.

The change is cosmetic, not structural. Same Informa sales team. Same Santa Clara Convention Center venue. Same November cadence. Same audience composition — Bay Area medtech engineers, R&D managers, startup founders, product managers building digital health and AI medtech, and regulatory specialists navigating novel device pathways. Same exhibitor pool of ~150 specialized suppliers. Same booth pricing carried forward from prior BIOMEDevice rate cards (around $50 per square foot starting). Same free-with-pre-registration expo admission model. If you exhibited in past years, your account rep is the same person and your floor map looks the same.

The reason the rename matters is search. Many exhibitors, attendees, and planners are still searching for the old name — which is why this page exists. If you're budgeting a 2026 conference calendar, sourcing booth quotes, or trying to figure out whether to send your team to Santa Clara, this guide walks through everything you'd want to know in one place.

BIOMEDevice Silicon Valley 2026: Dates, Venue, and Format at a Glance

Why the Bay Area Audience Makes BIOMEDevice Silicon Valley Different

The reason Informa keeps a Santa Clara show on the calendar — instead of consolidating its medtech footprint into MD&M West down in Anaheim — is that the Bay Area audience is structurally different from the production-OEM crowd that fills the Anaheim floor every February. Santa Clara pulls a tech-forward, startup-heavy population: engineers and R&D leads from emerging digital health, AI medtech, connected-device, and wearable-platform companies; product managers building SaMD (software as a medical device) and remote monitoring products; and regulatory specialists working novel 510(k) and De Novo pathways. Stanford, UCSF, and the surrounding venture-capital ecosystem feed the floor with the kind of attendee you do not see in equivalent volume at any other MD&M event.

Translation: BIOMEDevice / MEDevice Silicon Valley is an innovation-stage show. The buying conversations happening on the floor lean toward Class II devices that haven't yet been submitted for clearance, AI infrastructure decisions for medtech startups still building their first commercial product, contract manufacturing selection for early production runs of novel form factors, and regulatory consulting engagements for companies operating outside well-traveled FDA pathways. If your sales motion is built around production-scale OEM contracts and commoditized component buying, you'll get better ROI at MD&M West. If your sales motion is built around early-stage and growth-stage medtech buyers, Santa Clara concentrates the audience tighter than any other Informa show.

BIOMEDevice Silicon Valley 2026 vs. MD&M West vs. The Rest of the MD&M Family

If you're triaging where to spend your 2026 medtech trade-show budget, here's how Santa Clara compares to the other Informa events:

Show Dates Location Attendance Best For
BIOMEDevice / MEDevice Silicon Valley Nov 18–19, 2026 Santa Clara, CA ~1,200 Digital health, AI medtech, wearables, connected devices, startup discovery
MD&M West February 2026 Anaheim, CA ~7,000 Contract manufacturing, components, materials, full-scale production
MD&M East June 2026 New York, NY ~5,000 East Coast OEMs, packaging, automation, regulatory consulting
MD&M Midwest October 2026 Minneapolis, MN ~3,000 Midwest OEMs (Medtronic, Boston Scientific), precision machining
MD&M South April 2026 Charlotte, NC ~2,500 Southeast OEMs, sterilization, packaging, contract assembly

The most common pattern we see with digital health and AI medtech clients is a two-show strategy: BIOMEDevice / MEDevice Silicon Valley in November for innovation-stage discovery, and MD&M West in February for production-stage OEM pipeline. For the full model we use to allocate budget across multiple shows, see our medical conference marketing ROI playbook.

What Actually Happens at BIOMEDevice Silicon Valley 2026

The two-day format is dense. Three things are happening on the floor at any given moment:

  1. The expo hall. 150+ specialized suppliers across contract manufacturing, digital health platforms, IoT and connected-device infrastructure, additive manufacturing, diagnostics components, wearable form factors, regulatory consulting, and software testing services. Free-with-pre-registration admission means walk-up traffic is heavy on day one and tapers fast on day two. Plan your booth staffing accordingly — front-load energy on day one.
  2. Education tracks. 20+ hours of sessions across AI medtech, IoT and connected health, additive manufacturing, diagnostics, and regulatory strategy. The content skews practical and technical: engineering managers, regulatory leads, and startup CTOs as both speakers and the bulk of the audience. Less keynote theater, more applied workshops.
  3. The Innovation Showcase. A curated section for emerging companies. If you're a Series A or Series B medtech startup, the Innovation Showcase is usually a better fit than a standard 10x10 — heavier foot traffic from investors and corporate development scouts, and lower booth-build cost overall.

One important note: BIOMEDevice / MEDevice Silicon Valley is not a clinical show. There is no practicing-clinician audience here. If your buyer is an interventional cardiologist, a hospital pharmacist, or a radiologist, this is the wrong show — pick AAOS, HIMSS, RSNA, or your specialty's flagship clinical meeting instead. Santa Clara is for engineers, R&D, product, and regulatory.

Should You Exhibit at BIOMEDevice Silicon Valley 2026?

Yes, if you sell into the early-stage and growth-stage Bay Area medtech ecosystem: contract manufacturers targeting startup OEMs, digital health platform vendors, AI medtech infrastructure providers, IoT and connected-device tooling companies, regulatory consultants specializing in novel device pathways, additive manufacturing services for prototyping, and software testing services for SaMD products. Santa Clara concentrates this audience in two days at a relatively affordable price point ($7K–$15K all-in for a 10x10), with free-admission expo dynamics that drive strong walk-up traffic for a small show.

No, if your buyer is a high-volume production OEM (better fit at MD&M West), a practicing clinician (wrong audience entirely), or a hospital health-system buyer (HIMSS or HLTH). The show is also a poor fit for traditional component suppliers selling commodity parts into established programs — Santa Clara's audience buys for prototypes and pilots, not for production runs.

If you're on the fence, run the math the way our team runs it for clients: model the all-in 2-day cost (booth + freight + travel + staffing for 2–3 reps), divide by your average startup-OEM deal size and gross margin, and ask whether two to four signed pilots in the next 9 months would justify the spend. For digital health and AI medtech vendors with a real follow-up cadence, the answer is almost always yes. For vendors who treat the show as a brand-awareness exercise and never run a structured post-show outreach sequence, the answer is no. Our post-conference follow-up playbook covers the exact cadence we use to convert booth scans into signed pilots.

How to Plan for BIOMEDevice Silicon Valley 2026 Right Now

If the show is still six months out as you read this, here's the timeline that consistently produces the strongest ROI in the Santa Clara format:

For the canonical exhibitor planning resource on this event — including a deeper audience breakdown and our internal Buzzbox conference score — see the MEDevice Silicon Valley 2026 conference profile in our conference directory. For broader context on the show vs. the rest of the MD&M family, our BIOMEDevice Silicon Valley Santa Clara rebrand guide goes deeper on the naming history and venue specifics.